Cargando…

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease

The gut microbiome can impact brain health and is altered in Parkinson’s disease (PD). The vermiform appendix is a lymphoid tissue in the cecum implicated in the storage and regulation of the gut microbiota. We sought to determine whether the appendix microbiome is altered in PD and to analyze the b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Peipei, Killinger, Bryan A., Ensink, Elizabeth, Beddows, Ian, Yilmaz, Ali, Lubben, Noah, Lamp, Jared, Schilthuis, Meghan, Vega, Irving E., Woltjer, Randy, Pospisilik, J. Andrew, Brundin, Patrik, Brundin, Lena, Graham, Stewart F., Labrie, Viviane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823437/ https://www.ncbi.nlm.nih.gov/pubmed/33406628 http://dx.doi.org/10.3390/metabo11010029

Ejemplares similares

Hemispheric asymmetry in the human brain and in Parkinson’s disease is linked to divergent epigenetic patterns in neurons
por: Li, Peipei, et al.
Publicado: (2020)

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
por: Thirtamara-Rajamani, Keerthi, et al.
Publicado: (2017)

The enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases
por: Lubben, Noah, et al.
Publicado: (2021)

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022)

Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease
por: Vishweswaraiah, Sangeetha, et al.
Publicado: (2022)

Decreased Risk of Parkinson’s Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls
por: Bacelis, Jonas, et al.
Publicado: (2021)

Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease
por: Gordevicius, Juozas, et al.
Publicado: (2021)

Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room
por: Killinger, Bryan A., et al.
Publicado: (2019)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
por: George, Sonia, et al.
Publicado: (2021)

Introduction
por: Patrik, Brundin
Publicado: (2017)

The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?
por: Killinger, Bryan, et al.
Publicado: (2019)

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson’s disease etiology
por: Coetzee, Simon G., et al.
Publicado: (2016)

Vertebrate food products as a potential source of prion-like α-synuclein
por: Killinger, Bryan Andrew, et al.
Publicado: (2017)

Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis
por: Killinger, Bryan A., et al.
Publicado: (2023)

A novel automated morphological analysis of Iba1+ microglia using a deep learning assisted model
por: Stetzik, Lucas, et al.
Publicado: (2022)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis
por: Widner, Håkan, et al.
Publicado: (1988)

The Times They Are a-Changin’: Parkinson’s Disease 20 Years from Now
por: Brundin, Patrik, et al.
Publicado: (2018)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease
por: Graham, Stewart F., et al.
Publicado: (2018)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
por: Sardi, S. Pablo, et al.
Publicado: (2018)

Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)

Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines
por: Ventorp, Filip, et al.
Publicado: (2017)

What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
por: Dunning, Christopher J.R., et al.
Publicado: (2013)

Nilotinib – Differentiating the Hope from the Hype
por: Wyse, Richard K., et al.
Publicado: (2016)

The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
por: Rey, Nolwen L., et al.
Publicado: (2016)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation
por: Mezias, Christopher, et al.
Publicado: (2019)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis
por: Pai, Shraddha, et al.
Publicado: (2019)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials
por: Bousset, Luc, et al.
Publicado: (2016)

Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases
por: Lázaro, Diana F., et al.
Publicado: (2020)

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
por: Kulkarni, Aishwarya S, et al.
Publicado: (2022)

Role of Inflammation in Suicide: From Mechanisms to Treatment
por: Brundin, Lena, et al.
Publicado: (2017)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
por: Burbulla, Lena F., et al.
Publicado: (2021)

Growth Factors and Feeder Cells Promote Differentiation of Human Embryonic Stem Cells into Dopaminergic Neurons: A Novel Role for Fibroblast Growth Factor-20
por: Correia, Ana Sofia, et al.
Publicado: (2008)

Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
por: Gil, Joana MAC, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_for7j7p4sbbhltffbcau1d8h17